Professional Documents
Culture Documents
Department of Gerontological Nursing/Wound Care Management, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku,
Tokyo 113-0033, Japan
b
Faculty of Nursing, Josai International University, 1 Gumyo, Togane-shi, Chiba, Japan
c
Department of Nursing, Shukutoku University, 673 Nitonacho, Chuo-ku, Chiba-shi, Chiba, Japan
d
Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa-shi, Kanagawa, Japan
e
St. Lukes International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, Japan
f
Department of Breast Surgical Oncology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, Japan
g
Department of Dermatology, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
a b s t r a c t
Keywords:
Breast cancer
Malignant fungating wound
Wound care
Palliative
Nursing
Qualitative study
Purpose: Patients with malignant breast wounds (MBWs) have multiple symptoms. In particular, care for
exudates or peri-wound moisture-associated dermatitis (MAD) is difcult. However, MAD has not been
distinguished from peri-wound dermatitis. Therefore, care for patients with MAD has not been well
established. The aim of this study was to describe morphological characteristics of MAD in MBWs and
link morphological characteristics of MAD to related factors.
Methods: We conducted a qualitative descriptive study and a cross-sectional study. Data were collected
by qualitative participant observation and structured interviews. The qualitative descriptive study was
conducted using the morphoqualitative analysis method. Data analyses were performed using qualitative research methods. In the cross-sectional study, the participants were classied into 2 groups for
comparison: with MAD (MAD group) and without MAD (non-MAD group).
Results: Characteristics of 24 MBWs were examined. Morphoqualitative analyses of data generated 17
subcategories and 3 categories. We could morphologically dene MAD by ndings of radial shape
matching the dressing and half-fusiform shape over the dressing. Regarding factors related to MAD,
necrotic tissue type was signicantly more severe in the MAD group than in the non-MAD group
(p 0.048). Wound exudate leakage was signicantly more frequent in the MAD group than in the nonMAD group (p 0.013).
Conclusion: Our study provides several points for nursing MBWs. Morphoqualitative analyses of MAD are
quite important for evaluating possible causes of MAD as well as selecting effective interventions.
2013 Published by Elsevier Ltd.
Introduction
Breast cancer is the most frequent malignancy in women (Jemal
et al., 2011) and is one of the most common neoplasms metastasizing to the skin (Koga et al., 2010). In particular, any inltration of
the epithelium by tumour cells is dened as a malignant wound
674
675
Fig. 1. Image and detailed description of a malignant breast wound as described in morphoqualitative analyses.
676
care researchers (WOCN, H. S. and M. O.), who reached an agreement with the principal investigator.
Data collection related to parameters that may be related to MAD
To identify factors correlated with MAD, we also collected the
following data: In addition to the demographic and wound/skin
morphological data described above, the items on the Bates-Jensen
wound assessment tool (BWAT) (Bates-Jensen et al., 1992) and the
malignant wound assessment tool for research (MWAT-R) (Schulz
et al., 2009) were evaluated as parameters of MBWs. BWAT consists of 13 items: size, depth, edges, undermining, necrotic tissue
type, necrotic tissue amount, exudate type, exudate amount, skin
colour of the surrounding wound, peripheral tissue oedema,
induration, granulation tissue and epithelialisation. The surface
area, height, site (exure part or at part) and classication (fungating or ulcerative) of MBWs were collected from MWAT-R. The
validity and reliability of BWAT and MWAT-R have already been
conrmed previously (Bates-Jensen et al., 1992; Schulz et al., 2009).
The same researcher evaluated the items derived from these
assessment tools throughout the study. Inter-rater reliability of
BWAT was evaluated by calculating the rate of agreement on scores
for 24 photographs of MBWs by a plastic surgeon (T. N.), WOCN (H.
S.), and the researcher (r 0.72e0.91 for each item). The area of the
lesion was measured 3 times from each photograph using Image J
software (National Institutes of Health, Maryland, USA), and the
median value was used. The tumour height of MBWs was estimated
using Schulzs method with a cotton-tipped applicator (Schulz
et al., 2009).
The following data related to wound management within the
preceding month were collected by the participanteobserver study
(Savage, 2000) and to the structured interview: washing method,
number of wound dressing changes, type of dressing, type of
ointment, t of dressing and leakage of wound exudates (Grocott,
1997, 1998; Grocott and Cowley, 2001).
Data related to physical condition and quality of life were
collected from medical charts, participant observation or structured interview and included laboratory blood investigations, PS
(Alexander, 2009; de Haes et al., 2003), pain, upper extremity
lymphoedema, mobility of the arm, weakness of the skin, self care,
care support and occupation.
Statistical analysis of factors related to MAD
The participants were classied into 2 groups on the basis of the
characteristics in the abovementioned morphoqualitative analysis:
those with MAD (MAD group) and those without MAD (non-MAD
group). The data were then compared between the 2 groups. Values
were represented with the median (range) unless otherwise indicated. Differences between the two groups were analysed using
Fishers exact test or the ManneWhitney U-test. A p value <0.05
was considered statistically signicant. All analyses were performed using Statistical Analysis System Ver. 9.2 (SAS Institute Inc.,
Cary, NC, USA).
The protocol was approved by the Ethical Committee of the
Graduate School of Medicine, The University of Tokyo and by St.
Lukes International Hospital, Japan. Written informed consent was
obtained from all the participants.
Results
Twenty-four patients were eligible for participation in the study.
Patient characteristics are summarised in Table 1. The median age
(range) was 62.0 (36e81) years, and the median duration of
experience of malignant wounds was 14.5 (1e87) months. The
Table 1
Patient characteristics.
Age (years)
Duration of breast
cancer (months)
Duration of malignant
wound (months)
Oestrogen receptor
Progesterone receptor
HER-2
Operation type
Metastasesa
Location of malignant
wounds
Treatmentsa
Performance status
Presence of job
Comorbiditiesa
n 24
62.0 (36e81)
57.5 (3e161)
14.5 (1e87)
Positive
Negative
Positive
Negative
Positive
Negative
Yes
Partial mastectomy
Partial mastectomy axillary
dissection
Total mastectomy
Total mastectomy axillary
dissection
No
Lung
Liver
Bone
Brain
Breast
Sternal region
Axilla
Thoracoabdominaledorsal region
Brachial region
Hormone therapy
Chemotherapy
Molecular-targeted therapy
Radiation therapy (local)
Completely active
Restricted in physically strenuous
activity
Ambulatory and capable of self care
Capable of only limited self care
Cannot perform any self care
activities
Hypertension
Hyperthyroidism
Gynaecological disorder
Diabetes
Hyperlipidaemia
Dermatomyositis
Depression
13
11
11
13
10
14
1
2
(54.2)
(45.8)
(45.8)
(54.2)
(41.7)
(58.3)
(4.2)
(8.3)
1 (4.2)
7 (29.1)
13
11
5
11
0
16
3
3
1
1
6
17
7
0
3
13
(54.2)
(45.8)
(20.8)
(45.8)
(0.0)
(66.6)
(12.5)
(12.5)
(4.2)
(4.2)
(25.0)
(70.8)
(29.2)
(0.0)
(12.5)
(54.2)
6 (25.0)
2 (8.3)
0 (0.0)
3
4
3
3
2
1
1
1
(12.5)
(16.7)
(12.5)
(12.5)
(8.3)
(4.2)
(4.2)
(4.2)
677
Table 2
Morphological characteristics of the peri-wound skin around the malignant breast wounds (n 24).
[Location]
[Shape]
<Pigmentation (2)>
<Erythema (8)>
<Erythema accompanied by wheal (2)>
<Pigmentation (8)>
<Erythema (8)>
<Erythema
<Erythema
<Erythema
<Erythema
<Erythema
<Erythema
<Erythema
accompanied
accompanied
accompanied
(3)>
accompanied
accompanied
accompanied
by purpura (1)>
by wheal (1)>
by erosion (2)>
by purpura (1)>
by wheal (2)>
by erosion (1)>
<Pigmentation (1)>
<Erythema (3)>
<Purpura (14)>
<Erythema accompanied by bulla, pustule,
eschar and erosion (1)>
[ ]: category, < >: subcategory, Italic font: cancer site, Bold font: newly detected shape, (): number of codes.
Table 3
Patient characteristics in each group (n 23).
Age (years)
Duration of breast cancer
(months)
Duration of malignant
wounds (months)
Oestrogen
Negative
receptor
Positive
Progesterone
Negative
Positive
receptor
HER-2
Negative
Positive
Operation
Yes
No
Lung
Yes
metastasis
No
Liver
Yes
No
metastasis
Bone
Yes
No
metastasis
Location of
Breast
Sternal region
malignant
Axilla
wounds
Brachial region
Hormone
Yes
No
therapy
Chemotherapy Yes
No
MolecularYes
No
targeted
therapy
Performance
1
2
status
Moisture-associated
dermatitis (MAD)
group n 14
Non-MAD
group n 9
p value
62.0 (36e81)
70.0 (7e161)
61.0 (39e75)
58.0 (3e127)
0.950a
0.413a
15.5 (3e87)
14.0 (1e64)
0.776a
5
9
7
7
8
6
7
7
8
6
3
11
7
7
8
3
3
0
4
10
9
5
4
10
(35.7)
(64.3)
(50.0)
(50.0)
(57.1)
(42.9)
(50.0)
(50.0)
(57.1)
(42.9)
(21.4)
(78.6)
(50.0)
(50.0)
(57.2)
(21.4)
(21.4)
(0.0)
(28.6)
(71.4)
(64.3)
(35.7)
(28.6)
(71.4)
8 (57.1)
6 (42.9)
(55.6)
(44.4)
(55.6)
(44.4)
(66.7)
(33.3)
(33.3)
(66.7)
(33.3)
(66.7)
(22.2)
(77.8)
(44.4)
(55.6)
(88.9)
(0.0)
(0.0)
(11.1)
(22.2)
(77.8)
(77.8)
(22.2)
(33.3)
(66.7)
0.417b
8 (88.9)
1 (11.1)
0.176b
5
4
5
4
6
3
3
6
3
6
2
7
4
5
8
0
0
1
2
7
7
2
3
6
1.000b
1.000b
0.669b
0.400b
1.000b
1.000b
0.092b
1.000b
0.657b
1.000b
678
Table 4
Factors related to moisture-associated dermatitis (MAD) in breast cancer patients with malignant wounds (wound-related factors) (n 23).
MAD group
n 14
BWAT
Size
Depth
Edges
Undermining
Necrotic tissue type
Necrotic tissue amount
Exudate type
Exudate amount
Skin colour surrounding wound
Peripheral tissue oedema
Peripheral tissue induration
Granulation tissue
Epithelialisation
MWAT
Wound surface area (cm2)
Wound height (cm)
Wound site
Wound classication
80 cm2
>80 cm2
Shallow crater
Deep crater
Attached
Not attached
No
Yes
Thin yellow or less
Thick yellow or black
50%
>50%
Serous
Purulent
Small
Moderate or large
White or grey
Dark red or purple
No
Yes
No
Yes
Bright, beef red
Pink, dusky-red
50%
<50%
10
4
2
12
5
9
12
2
8
6
9
5
4
10
2
12
2
12
3
11
4
10
9
5
0
14
18.8
2.2
10
4
7
7
Flexure part
Flat part
Fungating
Ulcerative
Non-MAD
group n 9
(71.4)
(28.6)
(14.3)
(85.7)
(35.7)
(64.3)
(85.7)
(14.3)
(57.1)
(42.9)
(64.3)
(35.7)
(28.6)
(71.4)
(14.3)
(85.7)
(14.3)
(85.7)
(21.4)
(78.6)
(28.6)
(71.4)
(64.3)
(35.7)
(0.0)
(100.0)
(4.2e222.5)
(1.6e7.0)
(71.4)
(28.6)
(50.0)
(50.0)
7
2
3
6
3
6
9
0
9
0
6
3
5
4
5
4
3
6
5
4
4
5
4
5
1
8
7.0
0.7
5
4
8
1
p value
1.000b
(77.8)
(22.2)
(33.3)
(66.7)
(33.3)
(66.7)
(100.0)
(0.0)
(100.0)
(0.0)
(66.7)
(33.3)
(55.6)
(44.4)
(55.6)
(44.4)
(33.3)
(66.7)
(55.6)
(44.4)
(44.4)
(55.6)
(44.4)
(55.6)
(11.1)
(88.9)
0.343b
1.000b
0.502b
0.048b
1.000b
0.383b
0.066b
0.343b
0.179b
0.657b
0.417b
0.391b
0.139a
0.196a
0.657b
(0.2e113.1)
(2.0e4.5)
(55.6)
(44.4)
(88.9)
(11.1)
0.086b
method has been used in previous studies where wound morphologies such as round, map, rhombic oval, line, buttery and
leaf shapes were identied (Fujimoto et al., 2004; Kinoshita et al.,
2009; Nanjo et al., 2011). Notably, wound shapes analysed by this
method can suggest possible causal factors such as changes in patients positions and uncontrolled pressure (Fujimoto et al., 2004;
Table 5
Factors related to moisture-associated dermatitis (MAD) in breast cancer patients
with malignant wounds (factors related to local care) (n 23).
MAD group
n 14
Non-MAD
group n 9
p value
2 (1e6)
12 (85.7)
2 (14.3)
2 (1e4)
9 (100.0)
0 (0.0)
0.080a
0.502b
4
5
4
5
7
1.000b
5
9
5
9
5
(35.7)
(64.3)
(35.7)
(64.3)
(35.7)
9 (64.3)
11 (78.6)
3 (21.4)
(44.4)
(55.6)
(44.4)
(55.6)
(77.8)
1.000b
2 (22.2)
2 (22.2)
7 (77.8)
0.013b
0.089b
679
Conclusion
This study revealed the prevalence and morphoqualitative
characteristics of MAD surrounding MBWs.
It is important for nurses to understand the ndings of MAD
related to wound exudates (radial shape matching the dressing or
half-fusiform shape over the dressing) for appropriate skin care of
patients with MBWs. Our study is important for evaluating the
possible causes of MAD as well as selecting effective nursing interventions by nurses. In brief, nurses could provide necessary care
for patients with necrotic tissue type (thick and yellow or black
necrotic tissue) and wound exudate leakage.
Conict of interest
None declared.
Funding source
This research was supported by a grant from Yamaji Fumiko
Nursing Research Fund.
Acknowledgements
We express our deepest gratitude to all of the patients.
Furthermore, we greatly thank all the doctors and the nurses
belonging to the participating breast centre who assisted with and
supported this study.
References
Alexander, S., 2009. Malignant fungating wounds: epidemiology, aetiology, presentation and assessment. Journal of Wound Care 18 (7), 273e280.
Anazawa, S., 2005. Dressing: New Wound Management. Health Shuppan, Tokyo (in
Japanese).
Ando, M., Ando, Y., Hasegawa, Y., Shimokata, K., Minami, H., Wakai, K., et al., 2001.
Prognostic value of performance status assessed by patients themselves, nurses,
and oncologists in advanced non-small cell lung cancer. British Journal of
Cancer 85 (11), 1634e1639.
Ashino, Y., 2007. Wound Care for the Cancer Patients: Practice of Palliative Care.
Syorinsya, Tokyo (in Japanese).
Barker, C., Pistrang, N., Elliott, R., 2002. Research Methods in Clinical Psychology: an
Introduction for Students and Practitioners. J. Wiley, Oxford.
Bates-Jensen, B.M., Vredevoe, D.L., Brecht, M.L., 1992. Validity and reliability of the
pressure sore status tool. Decubitus 5 (6), 20e28.
Cameron, J., Powell, S., 1996. Contact kept to a minimum. Nursing Times 92 (39),
84e86.
Cox, J.D., Stetz, J., Pajak, T.F., 1995. Toxicity criteria of the Radiation Therapy
Oncology Group (RTOG) and the European Organization for Research and
Treatment of Cancer (EORTC). International Journal of Radiation Oncology,
Biology, Physics 31 (5), 1341e1346.
de Haes, H., Olschewski, M., Kaufmann, M., Schumacher, M., Jonat, W., Sauerbrei, W.,
2003. Quality of life in goserelin-treated versus cyclophosphamide
methotrexate uorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer
Research Association Trialists Group. Journal of Clinical Oncology: Ofcial
Journal of the American Society of Clinical Oncology 21 (24), 4510e4516.
Diggelmann, K.V., Zytkovicz, A.E., Tuaine, J.M., Bennett, N.C., Kelly, L.E., Herst, P.M.,
2010. Mepilex Lite dressings for the management of radiation-induced erythema: a systematic inpatient controlled clinical trial. The British Journal of
Radiology 83 (995), 971e978.
European Wound Management Association (EMWA), 2004. Position Document:
Wound Bed Preparation in Practice. MEP Ltd, London.
Finkelstein, D.M., Cassileth, B.R., Bonomi, P.D., Ruckdeschel, J.C., Ezdinli, E.Z.,
Wolter, J.M., 1988. A pilot study of the Functional Living Index-Cancer (FLIC)
scale for the assessment of quality of life for metastatic lung cancer patients. An
Eastern Cooperative Oncology Group study. American Journal of Clinical
Oncology 11 (6), 630e633.
Fujimoto, Y., Sanada, H., Sugama, J., 2004. The relationship between pressure ulcer
development and wheelchair position in the elderly: comparison between
lateral and wheelchair position. Journal of Japan Academy of Nursing Science 24
(4), 36e45 (in Japanese).
Gray, M., Black, J.M., Baharestani, M.M., Bliss, D.Z., Colwell, J.C., Goldberg, M., et al.,
2011. Moisture-associated skin damage: overview and pathophysiology. Journal
680
Mohammed, D., Matts, P.J., Hadgraft, J., Lane, M.E., 2011. Depth proling of stratum
corneum biophysical and molecular properties. The British Journal of Dermatology 164 (5), 957e965.
Murakami, M., Kuroda, Y., Sano, A., Okamoto, Y., Nishikawa, T., Nishimura, S., et al.,
2001. Validity of local treatment including intraarterial infusion chemotherapy
and radiotherapy for fungating adenocarcinoma of the breast: case report of more
than 8-year survival. American Journal of Clinical Oncology 24 (4), 388e391.
Nanjo, Y., Nakagami, G., Kaitani, T., Naito, A., Takehara, K., Lijuan, J., et al., 2011.
Relationship between morphological characteristics and etiology of pressure
ulcers in intensive care unit patients. Journal of Wound, Ostomy, and Continence Nursing: Ofcial Publication of The Wound, Ostomy and Continence
Nurses Society/WOCN 38 (4), 404e412.
Naylor, W., 2002. Malignant wounds: aetiology and principles of management.
Nursing Standard 16 (52), 45e56.
Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., et al.,
1982. Toxicity and response criteria of the Eastern Cooperative Oncology Group.
American Journal of Clinical Oncology 5 (6), 649e655.
Porock, D., Kristjanson, L., 1999. Skin reactions during radiotherapy for breast
cancer: the use and impact of topical agents and dressings. European Journal of
Cancer Care 8 (3), 143e153.
Probst, S., Arber, A., Faithfull, S., 2009. Malignant fungating wounds: a survey of
nurses clinical practice in Switzerland. European Journal of Oncology Nursing:
The Ofcial Journal of European Oncology Nursing Society 13 (4), 295e298.
Russell, B., Thorne, N.A., 1955. Skin reactions beneath adhesive plasters. Lancet 268
(6854), 67e70.
Savage, J., 2000. Participative observation: standing in the shoes of others? Qualitative Health Research 10 (3), 324e339.
Schulz, V., Triska, O.H., Tonkin, K., 2002. Malignant wounds: caregiver-determined
clinical problems. Journal of Pain and Symptom Management 24 (6), 572e577.
Schulz, V., Kozell, K., Biondo, P.D., Stiles, C., Martins, L., Tonkin, K., et al., 2009. The
malignant wound assessment tool: a validation study using a Delphi approach.
Palliative Medicine 23 (3), 266e273.
Sussman, C., Bates-Jensen, B.M., 2007. Wound Care: a Collaborative Practice Manual.
Wolters Kluwer Health/Lippincott Williams & Wilkins, Maryland.
Thiers, B.H., 1986. Dermatologic manifestations of internal cancer. CA: a Cancer
Journal for Clinicians 36 (3), 130e148.
World Union Wound Healing Societies (WUWHS), 2007. Principles of Best Practice:
Wound Exudate and the Role of Dressings. A Consensus Document. MEP Ltd, London.